March 29, 2026·daily

India NCLT Insolvency Resolution Filings — March 29, 2026

All six filings center on insolvency proceedings under IBC and NCLT, with five detailing BKM Industries Ltd's delayed financial results across FY23 and Q1 FY24 periods, revealing consistent zero revenue from non-operational manufacturing, narrowing net losses YoY (e.g., FY23 ₹655L vs FY22 ₹1,492L, H1 FY23 ₹115L vs H1 FY22 ₹565L), but persistent high leverage with current borrowings fixed at ₹12,411L against stable assets ~₹17,900L. Cash fluctuated sharply (up ₹171L to ₹190L in H1 FY23, down to ₹16L by Q3 FY23), underscoring liquidity strains amid CIRP. Post-NCLT approval of resolution plan, BKM is regularizing past compliances with board approvals on March 28, 2026, signaling potential operational revival. IFCI faces a new SFIO-initiated NCLT petition (CP 34/241-242/PB/2026) on pre-FY17 facilities (provisioned at net book ₹157.26cr as of Dec 31, 2025), adding sub-judice risks. Overarching themes include prolonged non-ops, balance sheet deleveraging needs, and regulatory regularization as turnaround catalysts, with negative sentiment across all (materiality 9/10) implying high-risk distress plays rather than growth opportunities.

6 high priority6 total filings

March 28, 2026·daily

India MCA Insolvency Liquidation Filings — March 28, 2026

Across the 7 filings in the India MCA Insolvency & Restructuring Monitor (March 28, 2026 period), a mixed landscape emerges with 2 positive resolutions (Moschip Technologies amalgamation approved; CIAN Agro's resolution plan for Shubhada Tool accepted), 3 neutral procedural meetings (Lactose India shareholders, Utkarsh Bank equity/unsecured creditors for amalgamation), and 2 negative ongoing proceedings (Torrent Pharma NCLT meeting notice; Baron Infotech 21st CoC under CIRP). No period-over-period financial trends (YoY/QoQ revenue, margins) or insider trading activity disclosed in any filing, limiting quantitative comparisons, but all highlight NCLT-driven restructuring via amalgamations and IBC processes without declines or flat metrics noted. Key implications: Positive sentiments signal streamlined operations and turnarounds (materiality 6-8/10), while negatives flag prolonged insolvency risks (materiality 9/10); pharma and banking sectors show active schemes, tech has both wins/losses. Portfolio pattern: 4/7 filings involve amalgamation meetings post-NCLT orders (Feb-Mar 2026), building toward Q2 2026 catalysts. Actionable: Monitor results announcements by March 30-April 2 for voting outcomes, potential share price catalysts in smallcaps.

7 high priority7 total filings

March 28, 2026·daily

India NCLT Insolvency Resolution Filings — March 28, 2026

Across 11 filings in the India Corporate Insolvency & NCLT stream, dominant themes include NCLT approvals for amalgamations and resolution plans (Moschip, CIAN Agro, Lactose India, Utkarsh SFB), signaling group restructuring for efficiency and cost synergies, with 5/11 filings positive on procedural advancements. Ongoing CIRP proceedings (Baron Infotech, Torrent Pharma) highlight persistent insolvency risks in tech/pharma, while Ashok Leyland's 18.55% pledge release marks a major de-risking event. No explicit YoY/QoQ financial trends disclosed across filings, but neutral sentiments prevail in procedural meetings (Lactose, Utkarsh), contrasting minor negatives like Airtel's ₹1.74L penalty. High materiality (avg 7.3/10) underscores time-sensitive catalysts like shareholder results by Mar 30 (Lactose) and CoC meetings (Baron Apr 2), implying portfolio-level opportunities in resolution turnarounds vs risks in unresolved CIRPs. TVS Motor's non-insolvency launch diversifies positive sentiment, but overall, restructuring momentum could unlock value in underperformers amid absent period comparisons.

8 high priority3 medium11 total filings

March 27, 2026·daily

India MCA Insolvency Liquidation Filings — March 27, 2026

The 7 filings highlight a surge in NCLT-driven restructuring activities, including demergers, amalgamations, capital reductions, and ongoing CIRP under IBC, with 4/7 involving direct NCLT approvals or applications as of late March 2026. Key period-over-period trend: Lactose India posted modest FY25 revenue growth of 2.2% YoY to ₹11,640 lakhs but PAT declined 24% YoY to ₹516 lakhs, contrasting VIPL's deepening losses (PAT -₹196 lakhs on ₹35 lakhs revenue); no other explicit YoY/QoQ data but schemes address legacy losses (e.g., Charms P&L debit wipeout). High consents dominate (96-100% from shareholders/creditors in KMSugar, Charms, Lactose), signaling stakeholder support for value unlock amid neutral/mixed sentiments (1 positive, 1 mixed, 5 neutral). Critical developments: Imminent EGMs (Lactose Mar28, Torrent Apr28) and appointed dates (KMSugar Apr1) create near-term catalysts, while Ansal's prolonged CIRP flags realty distress. Portfolio implications: Restructuring wave offers turnaround potential but with dilution/integration risks; monitor pharma/chemicals for capacity synergies vs real estate insolvency drag.

7 high priority7 total filings

March 27, 2026·daily

India NCLT Insolvency Resolution Filings — March 27, 2026

Across 14 filings in the India Corporate Insolvency & NCLT stream, a dominant theme is corporate restructuring via NCLT schemes under Sections 230-232, with 5 cases (K.M. Sugar Mills demerger, Lactose merger, Charms capital reduction, Torrent Pharma amalgamation, Refex scheme) aimed at unlocking value, capacity expansion, and balance sheet cleanup amid insolvency contexts. Period-over-period trends are sparse but reveal Lactose India FY25 revenue +2.2% YoY to ₹11,640L contrasted by PAT -24% YoY to ₹516L, while VIPL showed deepening losses (PAT -₹196L, revenue ₹35L); no broad margin compression or growth deceleration patterns emerge. Positive outliers include L&T's significant order wins (₹1,000-2,500 Cr), Adani Ports' Port of Refuge operationalization, and Ashok Leyland's battery business hire, signaling execution strength. Routine trading window closures for IndiGo, Ashok Leyland, and Maruti Suzuki precede Q4FY26 earnings, with TCS call on April 9; Ansal Properties' 50th COC highlights protracted CIRP. Market implications: Restructuring wave offers alpha in small-caps but flags dilution/integration risks; portfolio trend toward value unlock in stressed assets, monitor March/April catalysts for NCLT/EGM outcomes.

7 high priority7 medium14 total filings

March 26, 2026·daily

India MCA Insolvency Liquidation Filings — March 26, 2026

Across the three filings in the India MCA Insolvency & Restructuring Monitor, NCLT approvals signal accelerating IBC resolutions, with two positive outcomes (JSW Energy acquisition and Moschip amalgamation) outweighing one mixed case (Euro Ceramics sale amid pending litigations), highlighting a portfolio-level theme of value extraction from distressed assets. Key period-over-period trend: JSW's acquired RCRIPL saw revenue plunge 47.5% YoY from FY23 ₹101 Cr to FY24 ₹53 Cr, then stabilize +1.9% YoY to FY25 ₹54 Cr, indicating bottoming out post-acquisition. Critical developments include JSW Energy's ₹700.10 Cr rail infra buyout for power plant synergies and Moschip's subsidiary merger effective Apr 4, 2025, both boosting operational efficiency; Euro Ceramics' ₹42.9 Cr going-concern sale to Jaquar offers revival but litigation overhang tempers upside. Market implications point to turnaround opportunities in energy/infra and tech, with 2/3 filings positive (avg materiality 8.3/10), though revenue weakness in acquired assets flags integration risks. Overall, restructuring momentum supports selective longs in listed beneficiaries like JSW Energy and Moschip.

3 high priority3 total filings

March 26, 2026·daily

India NCLT Insolvency Resolution Filings — March 26, 2026

Across 14 filings in the India Corporate Insolvency & NCLT stream, dominant themes include NCLT-approved resolutions and acquisitions providing revival catalysts in ceramics, power infrastructure, and tech sectors, alongside routine trading window closures by six companies ahead of FY26 Q4 results. Positive insolvency outcomes for JSW Energy (rail infra acquisition), Euro Ceramics (sale to Jaquar), and MosChip (subsidiary amalgamation) signal portfolio-level turnaround opportunities, with JSW's target revenue stabilizing at Rs54cr FY25 after 47% YoY decline FY24. Tax penalties emerged as a counter-theme, impacting aviation (InterGlobe Rs43cr GST), banking (Yes Bank Rs0.8cr), and telecom (Airtel Rs0.1cr DoT), though contested with minimal expected impact. Bondada Engineering expanded via new renewable energy SPV, contrasting minor neutral events like ITC subsidiary dissolution (0.006% income contribution). No broad insider trading activity beyond window closures, but forward-looking board meetings post-Mar31 2026 create earnings catalysts; limited period data shows revenue stabilization in acquired assets amid neutral capital allocation.

4 high priority10 medium14 total filings

March 25, 2026·daily

India MCA Insolvency Liquidation Filings — March 25, 2026

In a quiet session for India MCA Insolvency & Restructuring Monitor, both Bloom Dekor Ltd and Unitech International Ltd reported progress in their CIRP via recent COC meetings, but highlighted ongoing delays and procedural hurdles with no financial recovery or positive operational metrics disclosed. Bloom Dekor (22nd COC meeting on March 19, 2026) received a resolution plan from Dr. Sunil Gupta but filed for a 120-day CIRP extension excluding litigation period until January 13, 2026, signaling prolonged uncertainty amid negative sentiment (Materiality 9/10). Unitech International (7th COC on March 24, 2026) unanimously approved RFRP and Evaluation Matrix (100% voting), but deferred key administrative items like legal counsel and auditor fees, yielding mixed sentiment (Materiality 8/10). No period-over-period financial trends, insider activity, capital allocation, or M&A valuations were reported, underscoring stalled recovery processes versus prior briefs. Cross-company pattern: Advanced CIRP stages (22nd vs 7th meeting) but persistent delays imply heightened liquidation risks and depressed valuations for these scrips. Market implications include limited near-term catalysts beyond NCLT rulings, advising avoidance for long-only portfolios while monitoring for distressed opportunities.

2 high priority2 total filings

March 25, 2026·daily

India NCLT Insolvency Resolution Filings — March 25, 2026

Across 17 filings, dominant themes include routine pre-earnings trading window closures for 5 companies (ITC, IDBI Bank, ONGC, Birlasoft, ICICI implied via ESOP), signaling Q4/FY26 results in early April 2026 with no disclosed financial trends or insider trades yet. Positive developments feature L&T's ₹1,000-2,500 Cr order win strengthening Northeast infra presence, Adani Enterprises' early ₹1,950 Cr NCD redemption reducing leverage, Infosys' dual positives (Finacle deal, Forrester AI leadership), and Airtel's orderly board transition for continuity. Insolvency filings (Bloom Dekor, Unitech) highlight prolonged CIRP delays with extension requests and deferred decisions, contrasting with neutral corporate updates. No period-over-period financial metrics disclosed, but capital allocation trends show debt reduction (Adani) and ESOP allotments (ICICI), implying stable financial health amid regulatory compliance. Portfolio implications: Watch banks/energy for earnings catalysts; favor infra/IT over distressed small-caps.

2 high priority15 medium17 total filings

March 24, 2026·daily

India MCA Insolvency Liquidation Filings — March 24, 2026

Across 8 insolvency and restructuring filings, overarching themes include procedural delays in CIRP (e.g., CoC meeting deferrals and claim amendments) affecting 4 companies, contrasted by 2 positive NCLT approvals for demerger and amalgamation schemes signaling potential resolutions. No explicit YoY/QoQ financial trends or operational metrics disclosed, limiting period-over-period insights, but high materiality (avg 8/10) underscores time-sensitive developments amid ongoing litigations and creditor meetings. Insider activity absent across all; capital allocation limited to Punj Lloyd's preferential share allotment to Adani Infra (475k shares at ₹2). Forward-looking catalysts cluster in late March-April 2026, including hearings, effective dates, and EGMs. Portfolio-level pattern: neutral-to-negative sentiment dominates (5/8 neutral/negative), with restructuring progress as key differentiator for relative outperformance. Market implications favor monitoring scheme implementers for turnaround alpha while avoiding prolonged CIRP names due to resolution risks.

8 high priority8 total filings

March 24, 2026·daily

India NCLT Insolvency Resolution Filings — March 24, 2026

Across 30 filings in the India Corporate Insolvency & NCLT stream, dominant themes include procedural delays in insolvency proceedings for consumer and realty firms (e.g., Future Consumer, Unitech International, Ansal Properties, Future Lifestyle) with negative/neutral sentiments, contrasted by strong capital allocation and growth signals in autos (TVS Motor's ₹570 Cr dividend, Maruti Suzuki's ₹10,189 Cr capacity expansion) and positives in pharma/M&A (Torrent Pharma amalgamation, Prima Plastics demerger). Limited period-over-period data highlights declining turnover at Adani Enterprises' media target IANS (down 9.6% YoY to ₹8.81 Cr in FY25, 25.7% over 2 years), signaling acquisition risks amid mixed sentiment. Multiple trading window closures (Apollo Hospitals, M&M, Tata Motors, L&T, Kansai Nerolac) flag Q4/FY26 earnings catalysts in April-May 2026, with no insider buys/sells but ESOP grants/allotments indicating retention. Capital returns favor shareholders (TVS 1200% interim div), while bank funding enhancements (Bondada ₹310 Cr) boost execution. Portfolio implications: Avoid insolvents with ongoing NCLT/CoC drags; rotate to autos/pharma for near-term yields and growth; monitor 19 new filings for escalation risks.

14 high priority16 medium30 total filings

March 23, 2026·daily

India NCLT Insolvency Resolution Filings — March 23, 2026

Across 23 filings in the India Corporate Insolvency & NCLT stream, a dominant theme is prolonged distress in insolvency proceedings, with 8 companies (e.g., Reliance Home Finance re-issuing Form G, Baron Infotech opening resolution plans without outcomes, Educomp restarting fresh CIRP within 100 days) showing no resolution and negative sentiment, signaling extended uncertainty and value erosion risks. Positive outliers include operational expansions like Adani Green adding 510.1 MW capacity (total renewable at 17,982.3 MW, no declines reported) and AI Champdany resolving NCLT petition via settlement. Neutral procedural updates dominate non-insolvency filings, such as trading window closures ahead of Q4/FY26 results (LIC Housing, TTK Prestige, TCS Apr 9, Kansai Nerolac May 6) and share allotments (Infosys 200,596 shares). Portfolio-level patterns reveal insolvency cluster in infra/finance/IT (Punj Lloyd liquidation mtg Mar 25, VAS Infra NCLT hearing Apr 21), contrasting bullish capacity/stake builds in renewables/healthcare/aviation/telecom. No aggregate YoY/QoQ financial trends available, but forward catalysts cluster in late Mar/early Apr (CoC mtgs) and May (earnings). Implications: Avoid deep exposure to ongoing CIRPs; favor operational positives like Adani/IndiGo for near-term momentum.

12 high priority11 medium23 total filings

March 23, 2026·daily

India MCA Insolvency Liquidation Filings — March 23, 2026

Across 9 insolvency filings, a dominant theme is prolonged Corporate Insolvency Resolution Processes (CIRP) with no resolutions achieved in 7 cases, signaling deepening distress in sectors like finance, infra, and tech amid ongoing NCLT/IBBC proceedings from March 2026. Key positive outlier: AI Champdany Industries resolved a petition via amicable settlement (NCLT order Mar 11, 2026), while Educomp Solutions faces fresh CIRP restart within 100 days from Mar 13, 2026, after SRA failure. No period-over-period financial trends (YoY/QoQ revenue/margins) reported in any filing, highlighting data opacity in distress situations; operational metrics absent, but procedural delays (e.g., 24th stakeholders meeting for Punj Lloyd) indicate multi-year deteriorations. Forward-looking catalysts cluster on Mar 25 (3 CoC/stakeholders meetings) and Apr 21 (VAS NCLT hearing), with neutral sentiments in 3 filings masking high risks (e.g., Vedanta NCLAT uncertainty). Portfolio-level pattern: 6/9 companies in active CIRP/liquidation with negative sentiment (avg materiality 9/10), implying systemic creditor fatigue and potential asset value erosion; investors should prioritize short/avoid strategies for unresolved names while eyeing turnaround in resolved outliers.

9 high priority9 total filings

March 22, 2026·daily

India NCLT Insolvency Resolution Filings — March 22, 2026

Tayo Rolls Limited (504961) remains entrenched in Corporate Insolvency Resolution Process (CIRP) initiated on October 30, 2019, marking over 6 years of insolvency proceedings with no resolution implementation. NCLT approved JBVNL's acquisition resolution plan on December 17, 2024, but NCLAT stay has stalled progress, leading to a deadlock in quarterly and annual statutory compliances for periods ended March 31, 2025. The erstwhile Compliance Officer, Harpreet Kaur Bhamra, has flagged inaction by the Successful Resolution Applicant (JBVNL) and Resolution Professional M. Anish Agarwal, requesting exemptions for key managerial personnel amid inoperative email and website. Sentiment is strongly negative with high materiality (9/10), signaling severe operational paralysis and regulatory uncertainty. No period-over-period financial trends available due to insolvency status, but prolonged CIRP highlights deteriorating governance and compliance trends versus resolved peers. Market implications include heightened illiquidity risk, potential delisting, and zero shareholder value until resolution, underscoring broader IBC delays in manufacturing sector.

1 high priority1 total filings

March 22, 2026·daily

India MCA Insolvency Liquidation Filings — March 22, 2026

The India MCA Insolvency & Restructuring Monitor highlights a single high-materiality (9/10) development in Tayo Rolls Limited, a steel rolls manufacturer under prolonged CIRP since October 30, 2019, with NCLT approval of JBVNL's resolution plan on December 17, 2024, stalled by NCLAT stay, leading to compliance deadlocks for FY ended March 31, 2025. No period-over-period financial trends available due to insolvency suspension, but ongoing inaction by RP M. Anish Agarwal and Successful Resolution Applicant JBVNL has rendered email/website inoperative, exacerbating statutory non-compliance. Negative sentiment dominates amid erstwhile Compliance Officer Harpreet Kaur Bhamra's plea for KMP liability exemption, signaling governance paralysis over 6+ years of CIRP. Market implications include heightened delisting/suspension risks for stock code 504961, with repeated BSE representations (April 6, 2019; December 18, 2024; May 30, 2025) underscoring persistent unresolved issues. Portfolio-level pattern: Isolated but emblematic of extended IBC delays in manufacturing sector, potentially pressuring creditor recoveries and investor confidence.

1 high priority1 total filings

March 21, 2026·daily

India NCLT Insolvency Resolution Filings — March 21, 2026

The India Corporate Insolvency & NCLT stream reveals heightened distress in smaller listed companies, with Radhagobind Commercial Limited's ongoing CIRP featuring a 5th CoC meeting on March 21, 2026, and no resolution plans approved despite deadline extensions to March 17, 2026 midnight, signaling prolonged uncertainty. Remedium Lifecare Limited faces fresh NCLT admission on March 17, 2026, for a ₹7.47 Cr operational debt default (principal ₹6.19 Cr + interest ₹1.28 Cr at 18% p.a. from Nov 7, 2023), imposing a Section 14 moratorium. In contrast, Delhivery Limited secured positive NCLT approval on March 20, 2026, for merging loss-making subsidiaries (SLPL negative reserves ₹-12 Cr) into its robust ₹11,843 Cr equity base as of Dec 31, 2024, aiming for operational streamlining. Adani Power and Larsen & Toubro report neutral investor/media events on March 24 and March 21, 2026, respectively, with no UPSI or financial disclosures. No explicit YoY/QoQ trends across filings, but insolvency cases dominate (3/6 filings, 100% negative sentiment), underscoring portfolio risks in commercial, healthcare, and logistics sectors versus stability in power/infra giants. Market implications include potential delisting/wipeout for insolvents and efficiency gains for Delhivery.

3 high priority3 medium6 total filings

March 21, 2026·daily

India MCA Insolvency Liquidation Filings — March 21, 2026

Three filings underscore escalating insolvency distress in Indian small-cap listed entities, with all exhibiting negative sentiment and maximum materiality (10/10). Radhagobind Commercial Limited (BSE:030070, CSE:539673) features in two updates, progressing from IRP appointment (Oct 30, 2025) and RP confirmation (Jan 27, 2026) to its 5th COC meeting on March 21, 2026, where CIRP costs, late resolution plans (up to March 17 midnight), and interim finance needs were discussed without resolution progress. Remedium Lifecare Limited faces fresh CIRP admission by NCLT Mumbai (March 17, 2026) on a ₹7.47 Cr operational debt default (principal ₹6.19 Cr post ₹12.17 Cr payments on ₹18.36 Cr invoices, plus ₹1.28 Cr interest at 18% p.a. from Nov 7, 2023 default), triggering moratorium under IBC Section 14. No period-over-period financial trends, insider activity, capital allocation, or positive guidance disclosed across filings, highlighting stalled operations and creditor dominance. Portfolio-level pattern: 100% negative outcomes, prolonged timelines (Radhagobind ~5 months to 5th COC; Remedium 2.5 years from default to admission), implying shareholder value erosion, trading suspensions, and liquidation risks. Market implications: Bearish for holdings, alpha in shorts or distressed debt plays.

3 high priority3 total filings

March 20, 2026·daily

India NCLT Insolvency Resolution Filings — March 20, 2026

Across 20 filings in the India Corporate Insolvency & NCLT stream, a bifurcated landscape emerges: 8 insolvency-related updates show mixed progress with 3 positive resolutions/dismissals (Zee Learn, Trustwave, Fenoplast withdrawal) offsetting ongoing CIRP delays and new applications (Baron Infotech 20th CoC, Heranba ₹2.63Cr claim), while 12 non-insolvency company updates are predominantly positive (10/12 bullish/neutral), highlighting board enhancements, investments, and AI partnerships in IT/logistics/auto sectors. Key period-over-period trend: Optare (Ashok Leyland sub) revenue surged 74% YoY to ₹1,233Cr in FY24-25 from ₹707Cr, following 208% prior YoY, signaling strong recovery outlier vs stagnant peers. Critical developments include NCLT extensions (Oberoi Realty to May 7, 2026) and CoC meetings (Baron, AGS, Quadrant), implying prolonged uncertainty in insolvencies; positive ESOP allotments across banks/IT (Wipro, ICICI, Yes Bank) indicate stable capital allocation with minimal dilution (<0.01% paid-up). Portfolio-level patterns: Insolvency cos average materiality 8/10 with negative/mixed sentiment (6/8), contrasting bullish non-insolvency (avg materiality 6/10); no insider trading or dividend/buyback activity noted, but capital reductions (Trustwave -90% equity to offset ₹6.21Cr losses) and investments (Ashok Leyland ₹375Cr) reveal deleveraging/reinvestment themes. Market implications: Opportunities in post-resolution rebounds (e.g., Zee Learn), risks in protracted CIRPs dragging valuations.

9 high priority11 medium20 total filings

March 20, 2026·daily

India MCA Insolvency Liquidation Filings — March 20, 2026

Across the 8 filings in the India MCA Insolvency & Restructuring Monitor, dominant themes include prolonged Corporate Insolvency Resolution Processes (CIRP) for 4 companies (Baron Infotech, AGS Transact, Quadrant Televentures, with multiple CoC meetings), a new Section 9 IBC petition against Heranba Industries for ₹2.63 Cr, delayed implementation of Oberoi Realty's ₹919.25 Cr resolution acquisition despite NCLT approval, positive petition dismissal for Zee Learn, NCLT-approved capital reduction for Trustwave Securities to offset ₹6.21 Cr losses, and Fenoplast's withdrawal of equity reduction record date post-resolution plan. No period-over-period financial comparisons (YoY/QoQ revenue, margins, ratios) or operational metrics disclosed in any filing, limiting quantitative trend analysis to procedural timelines; e.g., Baron at 20th CoC vs AGS at 9th indicates varying process maturity. Critical developments cluster around imminent CoC meetings (March 23 for Baron/Quadrant) and NCLT hearing (Heranba April 20), signaling potential resolution catalysts amid 6/8 negative/neutral sentiments. Portfolio-level pattern: 50% filings show ongoing CIRP delays (avg 6-18 months inferred from meeting counts), heightening volatility for listed scrips; acquirers like Oberoi present turnaround opportunities while vendors like Haresh Petrochem flag supplier risks. Market implications: Watch for resolution plan approvals to unlock value in distressed assets, but possession delays and small claims could pressure ops.

8 high priority8 total filings

March 19, 2026·daily

India NCLT Insolvency Resolution Filings — March 19, 2026

The 'India Corporate Insolvency & NCLT' stream reveals a surge in resolution activity with NCLT approvals for Rajeswari Infrastructure (Jan 13, 2026) and Jaiprakash Associates (Mar 17, 2026, claims ₹57,497 Cr), highlighting Adani Group's aggressive acquisition of distressed infra/aviation/power/fertilizer assets via resolution plans, positioning them for portfolio expansion. Ongoing CIRPs dominate with prolonged processes (e.g., JCT's 13th CoC meeting Mar 20, Compuage's 24th Mar 25, Ansal's 50th Mar 23), signaling persistent distress in infra/realty/textiles/IT hardware sectors amid multiple extensions. New CIRP admission for Supha Pharmachem (Mar 17, 2026, default ₹7.47 Cr) adds to pharma distress. Sparse period trends show ONGC's production declining mildly (FY25 -1.68% YoY to 41.08 MMTOE, 9MFY26 -0.55% YoY) but margins expanding (13.4% FY25 to 15.9% 9MFY26), with AAA rating affirmed. Positive non-insolvency updates include Adani's rights issue conversion (13.74 Cr shares), Wipro's GIFT City AI hub (150-500 seats), TCS partnerships, and Bharat Coking Coal's record 2.36L tonne booking. Market implications: Bullish for Adani ecosystem on cheap asset grabs, bearish for equity holders in CIRPs (e.g., Jaiprakash delisting at NIL), with catalysts in near-term CoC meetings and ONGC's Daman project (Mar-Apr 2026). Portfolio pattern: 9/20 filings insolvency-related, with Adani-linked positives offsetting distress.

11 high priority9 medium20 total filings

← All geographies